Newsroom
Filters: 2017
x
The newly elected President of Medicines for Europe – Marc-Alexander Mahl – […]
Read moreValue added medicines represent a major opportunity to improve patients’ […]
Read moreGeneric medicines have proven to be pivotal in increasing patient […]
Read moreBiosimilar medicines are transforming treatment by enabling better access to […]
Read moreWith more than 10 years of positive experience and 700 […]
Read moreA new study “Value Added Medicines: Time to Adjust the […]
Read more